An article published by the United Nations News claims that dexamethasone is a “no cure-all”, after reports from the United Kingdom claimed that the common steroid (dexamethasone) can help patients recover from severe cases of coronavirus.
“This is very welcome news for those patients with severe illness,” states World Health Organization Director-General Tedros Adhanom Ghebreyesus, in a virtual media briefing. However, the WHO Director-General warns that dexamethasone was shown to have no beneficial effect to those with mild symptoms of the disease, and those that do not require respiratory support.
“These drugs should only be used under close clinical supervision,” he adds.
According to Michael Ryan, Executive Director of WHO’s Health Emergencies Programme, the global agency is awaiting further details before it can draw clinical guidelines to share with authorities around the world.
“This is not for mild cases. This is not for prophylaxis,” states Michael Ryan, Executive Director of WHO’s Health Emergencies Programme. Moreover, Ryan appends that dexamethasone is associated with viral replication. Read more: Welcoming early results on the use of dexamethasone in sickest COVID-19 patients, WHO warns it’s “no cure-all”, an article by the United Nations News.
It may be recalled that BBC News published an article announcing that a lifesaving drug for coronavirus has been found. According to the article, the low-dose steroid treatment dexamethasone is a ‘major breakthrough in the fight against the deadly virus as per UK experts’.
Moreover, the drug is part of the world’s biggest trial testing existing treatments.
The drug dexamethasone cuts the risk of death by a third for patients on ventilators. For those on oxygen, it cuts death rate by a fifth. The drug, according to experts, could be a huge benefit to countries where the coronavirus disease is rampant. Read all the details here: Coronavirus: Dexamethasone proves first life-saving drug, an article by BBC News.